Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q3 EPS of ($0.73), $0.06 better than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.